|
gptkbp:instance_of
|
gptkb:biotechnology
|
|
gptkbp:acquisition
|
gptkb:Zymergen
|
|
gptkbp:ceo
|
gptkb:Jason_Kelly
|
|
gptkbp:collaboration
|
gptkb:University_of_Massachusetts
gptkb:Harvard_University
gptkb:Stanford_University
gptkb:University_of_California,_Berkeley
gptkb:MIT
|
|
gptkbp:employees
|
over 400
|
|
gptkbp:focus
|
cell programming
|
|
gptkbp:founded
|
gptkb:2008
|
|
gptkbp:founder
|
gptkb:Jason_Kelly
|
|
gptkbp:funding
|
gptkb:Series_A
gptkb:Series_B
Series D
Series C
Series E
|
|
gptkbp:headquarters
|
gptkb:Boston,_Massachusetts
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Ginkgo Bioworks, LLC
|
|
gptkbp:industry
|
gptkb:biotechnology
|
|
gptkbp:investment
|
$425 million
|
|
gptkbp:location
|
gptkb:United_States
|
|
gptkbp:notable_investments
|
gptkb:Y_Combinator
gptkb:Bessemer_Venture_Partners
gptkb:Khosla_Ventures
gptkb:Founders_Fund
gptkb:General_Catalyst
|
|
gptkbp:notable_project
|
gptkb:pharmaceuticals
agricultural biotechnology
COVID-19 testing
biomanufacturing
flavor and fragrance development
|
|
gptkbp:partnership
|
gptkb:Corteva
gptkb:Bayer
Avery Dennison
|
|
gptkbp:research_focus
|
genome editing
metabolic engineering
protein engineering
bioprocess optimization
microbial engineering
|
|
gptkbp:services
|
genetic engineering
organism design
|
|
gptkbp:stock_symbol
|
gptkb:DNA
|
|
gptkbp:subsidiary
|
Ginkgo Bioworks Agriculture
Ginkgo Bioworks Biosecurity
Ginkgo Bioworks Foundry
Ginkgo Bioworks Health
|
|
gptkbp:type
|
gptkb:public_company
|
|
gptkbp:website
|
www.ginkgobioworks.com
|
|
gptkbp:bfsParent
|
gptkb:Ginkgo_Bioworks
|
|
gptkbp:bfsLayer
|
4
|